| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/27/1997 | CN1158144A Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 08/27/1997 | CN1158121A Indolizine SPLA2 inhibitors |
| 08/27/1997 | CN1158087A Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 08/27/1997 | CN1157829A Process for producing platelet factor-4 |
| 08/27/1997 | CN1157822A Pharmaceutical compounds |
| 08/27/1997 | CN1157723A 洁阴散 San Jieyin |
| 08/27/1997 | CN1157719A Percutaneous applied medicine contained gestodene |
| 08/27/1997 | CA2198525A1 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism |
| 08/27/1997 | CA2197751A1 Growth promotion in chickens |
| 08/26/1997 | US5661187 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals |
| 08/26/1997 | US5661183 Prevention or treatment of neurodegeneration |
| 08/26/1997 | US5661174 Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use |
| 08/26/1997 | US5661173 Administering an enzyme inhibitor treating diabetes |
| 08/26/1997 | US5661167 Memory enhancement, preventing or slowing the affect of amnesia or memory deficits |
| 08/26/1997 | US5661162 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists |
| 08/26/1997 | US5661161 Administering to treat cancer in mammals |
| 08/26/1997 | US5661159 Quinolylbenzofuran derivatives as leukotriene antagonists |
| 08/26/1997 | US5661145 Treating or preventing atherosclerosis or reducing plasma cholesterol levels |
| 08/26/1997 | US5661143 Inhibits (de)polymerization of tubulin to form cellular microtubes; anticarcinogenic,-tumor, inflammatory and wound healing agents; immunology; angiogenesis inhibitors |
| 08/26/1997 | US5661140 Treating psoriasis |
| 08/26/1997 | US5661136 2-halo-2'-fluoro ARA adenosines as antinoplastic agents |
| 08/26/1997 | US5661127 Peptide compositions with growth factor-like activity |
| 08/26/1997 | US5661009 Providing host cell transformed with dna encoding a consensus human leukocyte interferon, culturing cell to effect expression of dna |
| 08/26/1997 | US5661007 Culturing; recovering; purification; administering to induce bone and/or cartilage formation |
| 08/26/1997 | US5661004 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 08/26/1997 | US5660859 Gelation of low-molecular weight polymer in water using calcium acetate at room temperature; drug capsules; dental products; cosmetics; cariers |
| 08/26/1997 | US5660835 Method of treating adenosine depletion |
| 08/26/1997 | US5660829 Process for antibody directed enzyme prodrug therapy |
| 08/26/1997 | US5660824 Muscle trophic factor |
| 08/26/1997 | US5660813 Method of screening of angiotens in II type I receptor antagonists |
| 08/26/1997 | CA2149245C Novel isoxazolines as antiinflammatory agents |
| 08/26/1997 | CA2140344C Antiinflammatory indolinyl n-hydroxyurea and n-hydroxamic acid derivatives |
| 08/26/1997 | CA1339356C Human platelet-derived growth factor receptor |
| 08/22/1997 | CA2198176A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/21/1997 | WO1997031000A1 Quinolones and their therapeutic use |
| 08/21/1997 | WO1997030151A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation |
| 08/21/1997 | WO1997030085A1 Troponin subunits and fragments useful as angiogenesis inhibitors |
| 08/21/1997 | WO1997030069A1 17-beta-cyclopropyl(amino/oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20-lyase |
| 08/21/1997 | WO1997030056A1 Spiro-ketal derivatives and their use as therapeutic agents |
| 08/21/1997 | WO1997030055A1 Spiro-ketal derivatives and their use as therapeutic agents |
| 08/21/1997 | WO1997030053A1 Farnesyl transferase inhibitors |
| 08/21/1997 | WO1997030048A1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 08/21/1997 | WO1997030046A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 08/21/1997 | WO1997030045A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 08/21/1997 | WO1997030044A1 Quinazoline compounds |
| 08/21/1997 | WO1997030042A1 Polyester cyclic compounds, their complexes and bonded bodies |
| 08/21/1997 | WO1997030027A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors |
| 08/21/1997 | WO1997029752A1 Storage-stable prostaglandin compositions |
| 08/21/1997 | WO1997029748A1 Substituted biphenyl isoxazole sulfonamides |
| 08/21/1997 | WO1997029746A1 Inhibition of protein glycation and prevention of vasculopathy |
| 08/21/1997 | WO1997029745A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/21/1997 | WO1997029739A2 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| 08/21/1997 | WO1997023613A3 Cell activation process and reagents therefor |
| 08/21/1997 | WO1997014806A3 Delivery of biologically active polypeptides |
| 08/21/1997 | CA2634973A1 Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 08/21/1997 | CA2246712A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation |
| 08/21/1997 | CA2246578A1 Novel human myeloid terminal differentiation response gene |
| 08/21/1997 | CA2245830A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors |
| 08/21/1997 | CA2245684A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 08/21/1997 | CA2244823A1 17-beta-cyclopropyl(amino/oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20-lyase |
| 08/21/1997 | CA2241891A1 Quinolones and their therapeutic use |
| 08/21/1997 | CA2240043A1 Substituted biphenyl isoxazole sulfonamides |
| 08/21/1997 | CA2230639A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/20/1997 | EP0790254A1 Pseudopeptides derived from neurokinines, process of preparation and pharmaceutical compositions comprising them |
| 08/20/1997 | EP0790250A2 Inhibitors of biogenic amine transporters |
| 08/20/1997 | EP0790248A1 3-Aza-piperidone- (tetrahydropyrimidin-2-one) and 3-oxa-piperidone (1,3 oxazin-2-one) derivatives, their preparation and their use as tachykinin/neurokinin antagonists |
| 08/20/1997 | EP0790245A1 Substituted Thiophenylalkenylcarbonylguanidide, method for their preparation, their use as medicinal or diagnostic agent as well as medicament containing them |
| 08/20/1997 | EP0790239A1 Novel 4-phenyl-2-(piperazinyl/perhydrodiazepinyl/aminoalkyl)carbonylmethyl)-1,4-dihydropyridine-3,5-dicarboxylic acid derivatives as bradykinin receptor antagonists |
| 08/20/1997 | EP0790236A1 Pro-drugs of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one |
| 08/20/1997 | EP0790053A1 Use of 2-amino-alkane-1,3-diol to reduce hairloss and/or to induce and stimulate hairgrowth |
| 08/20/1997 | EP0789764A1 A novel family of protease inhibitors, and other biologic active substances |
| 08/20/1997 | EP0789760A2 Enzymatic method for modification of recombinant polypeptides |
| 08/20/1997 | EP0789759A1 Modified factor vii |
| 08/20/1997 | EP0789757A1 Transgenic organisms and their uses |
| 08/20/1997 | EP0789713A1 Antibodies |
| 08/20/1997 | EP0789707A1 Amino acid nucleic acids |
| 08/20/1997 | EP0789699A1 SPIRO HETEROCYCLE-IMIDAZO(1,2-a]INDENO(1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 08/20/1997 | EP0789695A2 Thiepane compounds inhibiting and detecting hiv protease |
| 08/20/1997 | EP0789690A1 N-aryl and n-heteroaryl-1,2-diaminocyclobutene-3,4-diones with smooth muscle relaxing activities |
| 08/20/1997 | EP0789687A1 Ep 2?-receptor agonists as agents for lowering intraocular pressure |
| 08/20/1997 | EP0789578A1 Multicatalytic protease inhibitors |
| 08/20/1997 | EP0789575A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/20/1997 | EP0789574A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/1997 | EP0789571A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase |
| 08/20/1997 | EP0789567A1 A method for treating vascular headaches |
| 08/20/1997 | EP0789566A1 Hydroxyethyl aminimides |
| 08/20/1997 | EP0789553A1 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 08/20/1997 | EP0752813A4 Inhibitors of metazoan parasite proteases |
| 08/20/1997 | EP0679155B1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 08/20/1997 | EP0662954B1 Novel vitamin d analogues |
| 08/20/1997 | EP0629197B1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 08/20/1997 | EP0620737B1 Use of LACTOFERRIN iN the manufacture of a medicament for treating RHEUMATISM |
| 08/20/1997 | CN1157617A Heterobicyclic derivatives |
| 08/20/1997 | CN1157615A Heterocyclic tachykinin receptor antagonists |
| 08/20/1997 | CN1157614A Process for synthesis of substituted sulphoxides |
| 08/20/1997 | CN1157609A Heterocyclic derivative and medicine |
| 08/20/1997 | CN1157571A Use of IL-4 for potentiation of chemotherapeutic agents |
| 08/20/1997 | CN1157570A Intracellular delivery of chemical agents to specific cell type |
| 08/20/1997 | CN1157569A Anti-adhesion agent |
| 08/20/1997 | CN1157568A Hard tissue stimulating agent |